Oxidative metabolites of estrogen and estrogen receptor-mediated genomic and nongenomic signal transduction contribute to the carcinogenicity of estrogen, and thus could initiate, promote, or progress breast cancer [6]. Here, ESR1 is linked to breast carcinoma.